Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
URGN

Updated 10/6/2026, 8:26 AM ET.

URGN

UroGen Pharma Ltd.

Sale$37,383

Schoenberg Mark

Chief Medical Officer

871 shat $42.92Filed Sep 9, 2:37 PM ETFiling
URGN

UroGen Pharma Ltd.

Sale$64,618

Smith Jason Drew

General Counsel

1,519 shat $42.54Filed Sep 9, 2:35 PM ETFiling
URGN

UroGen Pharma Ltd.

Sale$2,854,853

Schoenberg Mark

Chief Medical Officer

60,677 shat $47.05Filed Aug 24, 5:03 PM ETFiling
URGN

UroGen Pharma Ltd.

Sale$400,000

Schoenberg Mark

Chief Medical Officer

10,000 shat $40.00Filed Jul 10, 2:17 PM ET
Filing

Read from public SEC filings. Not financial advice.